Schonfeld Strategic Advisors’s FibroGen FGEN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-1,968
| Closed | -$43.9K | – | 1989 |
|
2024
Q2 | $43.9K | Buy |
1,968
+388
| +25% | +$8.66K | ﹤0.01% | 1808 |
|
2024
Q1 | $92.8K | Buy |
+1,580
| New | +$92.8K | ﹤0.01% | 1669 |
|
2023
Q3 | – | Sell |
-2,209
| Closed | -$149K | – | 1771 |
|
2023
Q2 | $149K | Buy |
+2,209
| New | +$149K | ﹤0.01% | 1568 |
|
2022
Q4 | – | Sell |
-1,983
| Closed | -$645K | – | 2631 |
|
2022
Q3 | $645K | Buy |
+1,983
| New | +$645K | 0.01% | 1547 |
|
2021
Q2 | – | Sell |
-1,592
| Closed | -$1.38M | – | 2003 |
|
2021
Q1 | $1.38M | Buy |
+1,592
| New | +$1.38M | 0.02% | 749 |
|
2019
Q1 | – | Sell |
-2,852
| Closed | -$3.3M | – | 1072 |
|
2018
Q4 | $3.3M | Buy |
+2,852
| New | +$3.3M | 0.13% | 225 |
|
2016
Q3 | – | Sell |
-1,609
| Closed | -$660K | – | 456 |
|
2016
Q2 | $660K | Buy |
+1,609
| New | +$660K | 0.15% | 189 |
|